Cart summary

You have no items in your shopping cart.

MTT5

SKU: orb2663679

Description

MTT5, a TLR7 agonist, is conjugated to Deruxtecan to create a bifunctional agent for HER2-positive solid tumors. This conjugate combines targeted tumor cell killing with immune system activation via TLR7 stimulation, supporting research in antibody-drug conjugates and immuno-oncology for both in vitro and in vivo studies.

Research Area

Immunology & Inflammation

Images & Validation

Key Properties

MW453.49
FormulaC22H27N7O4
TargetTLR

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

MTT5 (orb2663679)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%